Related Experiment Video
Updated: May 13, 2026
09:03
Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow
Published on: March 17, 2023
Commercialization of regenerative medicine: learning from spin-outs
Anna French1, R Lee Buckler, David A Brindley
1Nuffield Division of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, United Kingdom. anna.french@ndcls.ox.ac.uk
Rejuvenation Research
|March 9, 2013
Summary
Commercializing regenerative medicine requires addressing healthcare infrastructure compatibility, biomanufacturing scalability, and reimbursement models. Key advice from industry leaders aims to accelerate the translation of cellular and gene therapies from research to market.
Area of Science:
- Regenerative Medicine
- Cellular Therapies
- Gene Therapies
Background:
- Meeting on commercializing regenerative medicine research hosted by Oxbridge Biotech Roundtable (OBR) at the University of Oxford.
- Featured case studies from successful regenerative medicine companies: Cell Medica, Reneuron, and Intercytex.
- OBR is a multi-stakeholder initiative fostering dialogue in the healthcare and life sciences industry.
Framework:
- Discussion of regenerative medicine commercialization challenges.
- Exploration of cellular and gene therapy subsets.
- Focus on accelerating the translation of research from lab to marketplace.
Implementation:
- Assessing compatibility of regenerative therapies with existing healthcare infrastructure.
- Addressing biomanufacturing challenges, including scalability and comparability.
- Evaluating the amenability of regenerative therapies to current reimbursement and investment models.
Implications:
- Provides insights for researchers and industry professionals in regenerative medicine.
- Highlights key considerations for successful commercialization of cellular and gene therapies.
- Offers actionable advice from experienced leaders to navigate the translation pathway.
Related Concept Videos
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:19Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
00:57Embryonic Stem Cells
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...